Epigenetic modulators as therapeutic targets in prostate cancer

Prostate cancer is one of the most common non-cutaneous malignancies among men worldwide. Epigenetic aberrations, including changes in DNA methylation patterns and/or histone modifications, are key drivers of prostate carcinogenesis. These epigenetic defects might be due to deregulated function and/...

Descripción completa

Detalles Bibliográficos
Autores principales: Graça, Inês, Pereira-Silva, Eva, Henrique, Rui, Packham, Graham, Crabb, Simon J., Jerónimo, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025578/
https://www.ncbi.nlm.nih.gov/pubmed/27651838
http://dx.doi.org/10.1186/s13148-016-0264-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025578/
https://www.ncbi.nlm.nih.gov/pubmed/27651838
http://dx.doi.org/10.1186/s13148-016-0264-8

Ejemplares similares